Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Kidney Disease II: Clinical Manifestations
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 25, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
V Kukes1, N Chebyshev1, L Pavlova1
1Sechenov First Moscow State Medical University, Russia.
Statins may slow aging and reduce cardiovascular disease risk by increasing telomerase activity. However, this may also increase cancer risk by upregulating the hTERT gene, necessitating safety studies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: